1. Home
  2. JZ vs NXL Comparison

JZ vs NXL Comparison

Compare JZ & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jianzhi Education Technology Group Company Limited

JZ

Jianzhi Education Technology Group Company Limited

N/A

Current Price

$1.12

Market Cap

6.6M

Sector

Real Estate

ML Signal

N/A

Logo Nexalin Technology Inc.

NXL

Nexalin Technology Inc.

N/A

Current Price

$6.73

Market Cap

7.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JZ
NXL
Founded
2011
2010
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Medical Specialities
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.6M
7.5M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
JZ
NXL
Price
$1.12
$6.73
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.9M
139.6K
Earning Date
04-13-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
39.76
EPS
N/A
N/A
Revenue
N/A
$301,647.00
Revenue This Year
N/A
$15.52
Revenue Next Year
N/A
$100.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
78.78
52 Week Low
$0.09
$0.22
52 Week High
$5.46
$7.69

Technical Indicators

Market Signals
Indicator
JZ
NXL
Relative Strength Index (RSI) 38.61 96.86
Support Level $0.68 $0.44
Resistance Level $1.29 N/A
Average True Range (ATR) 0.56 0.18
MACD -0.15 0.69
Stochastic Oscillator 0.69 92.77

Price Performance

Historical Comparison
JZ
NXL

About JZ Jianzhi Education Technology Group Company Limited

Jianzhi Education Technology Group Co Ltd engages in developing educational content to fulfill the massive demand for high-quality, professional development training resources in China. The company and its subsidiaries VIE and VIEs generate subscription revenue through selling subscriptions to online learning platforms, higher education institutions, and other institutional customers under a B2B2C model mainly through the platform of Sentu Academy; offering subscriptions concerning educational content in mobile video packages directly to end users under a B2C model through the platforms such as Fish Learning or Light Class, etc. It has single operating segment: Educational content services and other services and IT-related solution services.

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products and bioelectronic medical technology to treat anxiety and insomnia without drugs or psychotherapy. The Company has developed the Generation 1 (Gen 1) medical device, a cranial electrotherapy stimulation (CES) device classified by the U.S. Food and Drug Administration (FDA) as a Class II device. The Company operates as a single operating and reportable segment, focused on the design and development of innovative neurostimulation products. The Company focuses on treating mental health conditions without reliance on drugs or psychotherapy. Geographically, it generates sales in the USA and China, with China generating the maximum sales.

Share on Social Networks: